Articles related to Hepatology

Boehringer Ingelheim’s SYNCHRONIZE-1 phase 3 trial reported 16.6% average body weight reduction with survodutide, a dual GLP-1/glucagon receptor agonist, over 76 weeks in adults without type 2 diabetes.

A systematic review of five studies found no consistent short-term safety signals in renal, hepatic, or cardiometabolic outcomes among adolescents using creatine monohydrate.

US poison centers logged a 1,200% rise in kratom calls over a decade, with 2025 hitting 3,434 cases and 233 deaths tied to use during the study period.

These results suggest that PARP inhibition represents a potential treatment strategy in HRR-deficient advanced biliary tract cancer, including the potential platform to investigate novel combination treatment strategies as well as consideration for a more selective biomarker selection.

Most alcohol-free and low alcohol beverages, even those described as zero alcohol or 0.0%, can legally contain very small levels of alcohol, typically less than 0.5%.

“Mean LOS post-transplant was significantly shorter in the post-APP cohort (P = .005). The mean LOS for the pre- and post-APP cohorts were 22.4 and 16.5 days, respectively.”